Naïve human macrophages are refractory to SARS-CoV-2 infection and exhibit a modest inflammatory response early in infection
File(s)viruses-14-00441-v2.pdf (813.34 KB)
Published version
Author(s)
Zhang, Ziyun
Penn, Rebecca
Barclay, Wendy S
Giotis, Efstathios
Type
Journal Article
Abstract
Involvement of macrophages in the SARS-CoV-2-associated cytokine storm, the excessive secretion of inflammatory/anti-viral factors leading to the acute respiratory distress syndrome (ARDS) in COVID-19 patients, is unclear. In this study, we sought to characterize the interplay between the virus and primary human monocyte-derived macrophages (MDM). MDM were stimulated with recombinant IFN- and/or infected with either live or UV-inactivated SARS-CoV- 2 or with two reassortant influenza viruses containing external genes from the H1N1 PR8 strain and heterologous internal genes from a highly pathogenic avian H5N1 or a low pathogenic human seasonal H1N1 strain. Virus replication was monitored by qRT-PCR for the E viral gene for SARS- CoV-2 or M gene for influenza and TCID50 or plaque assay, and cytokine levels were assessed semiquantitatively with qRT-PCR and a proteome cytokine array. We report that MDM are not susceptible to SARS-CoV-2 whereas both influenza viruses replicated in MDM, albeit abortively.
We observed a modest cytokine response in SARS-CoV-2 exposed MDM with notable absence of IFN-β induction, which was instead strongly induced by the influenza viruses. Pre-treatment of MDM with IFN-α enhanced proinflammatory cytokine expression upon exposure to virus. Together, the findings concur that the hyperinflammation observed in SARS-CoV-2 infection is not driven by macrophages.
We observed a modest cytokine response in SARS-CoV-2 exposed MDM with notable absence of IFN-β induction, which was instead strongly induced by the influenza viruses. Pre-treatment of MDM with IFN-α enhanced proinflammatory cytokine expression upon exposure to virus. Together, the findings concur that the hyperinflammation observed in SARS-CoV-2 infection is not driven by macrophages.
Date Issued
2022-02-21
Date Acceptance
2022-02-18
Citation
Viruses, 2022, 14 (2), pp.1-10
ISSN
1999-4915
Publisher
MDPI AG
Start Page
1
End Page
10
Journal / Book Title
Viruses
Volume
14
Issue
2
Copyright Statement
© 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
License URL
Identifier
https://www.mdpi.com/1999-4915/14/2/441
Subjects
Science & Technology
Life Sciences & Biomedicine
Virology
macrophages
SARS-CoV-2
influenza
infectivity
cytokines
INTERFERON
CYTOKINES
CELLS
ACE2
SARS-CoV-2
cytokines
infectivity
influenza
macrophages
Cell Line
Cell Line, Tumor
Cells, Cultured
Cytokines
Humans
Inflammation
Influenza A Virus, H1N1 Subtype
Influenza A Virus, H5N1 Subtype
Interferon-alpha
Macrophages
Male
SARS-CoV-2
Virus Replication
Cells, Cultured
Cell Line
Cell Line, Tumor
Macrophages
Humans
Inflammation
Interferon-alpha
Cytokines
Virus Replication
Male
Influenza A Virus, H5N1 Subtype
Influenza A Virus, H1N1 Subtype
SARS-CoV-2
0605 Microbiology
Publication Status
Published
Date Publish Online
2022-02-21